Non Hodgkin Lymphoma News and Research

RSS
FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Anaplastic large cell lymphoma: Defense mechanism against certain drugs promotes cancer growth

Breast cancer simulation models can guide screening recommendations for women

Breast cancer simulation models can guide screening recommendations for women

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Gilead and Kite to present data from cell therapy research at 25th EHA Virtual Congress

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Phase III clinical trial shows benefit of rituximab for pediatric Burkitt lymphoma

Scientist explore potential drugs to prevent cell resistance in different types of cancer

Scientist explore potential drugs to prevent cell resistance in different types of cancer

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

EPFL scientists identify new therapeutic target for Non-Hodgkin lymphoma

EPFL scientists identify new therapeutic target for Non-Hodgkin lymphoma

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Study finds improvements in survival rates for all cancers in young adults

Study finds improvements in survival rates for all cancers in young adults

Cancer risk in psoriatic patients

Cancer risk in psoriatic patients

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

Study shows potential new approach to treating two common subtypes of lymphoma

Study shows potential new approach to treating two common subtypes of lymphoma

Recommended amounts of physical activity associated with reduced risk for seven cancers

Recommended amounts of physical activity associated with reduced risk for seven cancers

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models

Novel and targeted cellular product causes cell death in non-Hodgkin lymphoma models